This section presents data and statistics on asthma deaths, hospitalisations and prevalence in New Zealand children. You can download factsheets from the Downloads box.
Second-hand smoke exposure , nitrogen dioxide exposure [2,3] and indoor dampness and mould  can all cause and/or worsen asthma in children. Outdoor air pollution is also linked to asthma exacerbation .
On this page
Each year, a small number of children die from asthma
In 2016 there were over 6000 hospitalisations for asthma in children
Asthma hospitalisation rates were higher for young children
Pacific children have the highest asthma hospitalisation rates
Auckland, Lakes, Whanganui and Hutt DHBs had the highest asthma hospitalisation rates
Children living in the most deprived areas have higher asthma hospitalisation rates
In 2016/17 about 114,000 children had medicated asthma – a decrease from 2015/16
Higher rates of medicated asthma among Māori children and in more deprived areas
Whanganui, MidCentral and Hutt Valley DHBs had the highest rates of medicated asthma
Information about the data
A small number of children die from asthma each year in New Zealand. In 2014, four children died from asthma (Figure 1).
Figure 1: Annual number of asthma deaths, children aged 0–14 years, 2001–2014
Source: New Zealand Mortality Collection
In 2016, there were 6271 hospitalisations for asthma (including wheeze) among children aged 0–14 years.
The age-standardised rate for asthma hospitalisations increased from 2002 (473 per 100,000) to 2016 (688 per 100,000) (Figure 2).
Figure 2: Asthma hospitalisation rate, children aged 0–14 years, 2001–2016
In 2016, children aged 0–4 years had a much higher asthma hospitalisation rate (1396 per 100,000) than children aged 5–9 years (433 per 100,000) or 10–14 years (217 per 100,000).
In 2016, the asthma hospitalisation rate was much higher in Pacific children (Figure 3).
Figure 3: Asthma hospitalisation rate, by ethnic group, children aged 0–14 years, 2016
In 2016, the asthma hospitalisation rate was much higher for children living in more deprived areas (NZDep2013 quintile 5) (Figure 4).
Figure 4: Asthma hospitalisation rate, by NZDep2013 quintiles, children aged 0–14 years, 2016
In 2016, the highest asthma hospitalisation rates were in Auckland, Lakes, Whanganui and Hutt DHBs. See the factsheet for more details (in the Downloads box).
In 2016/17, 14.3% of children aged 2–14 years had asthma and were taking medication (inhalers, medicine, tablets or pills) for it. This is about 114,000 children.
The percentage of children with medicated asthma decreased from 16.6% in 2015/16 to 14.3% in 2016/17.
Across age groups, the rates of medicated asthma were 12.4% for children aged 2–4 years, 16.3% for children aged 5–9 years, and 13.3% for children aged 10–14 years.
In 2016/17, the highest rate of medicated asthma was among Māori children (17.8%) (Figure 5).
Figure 5: Prevalence of medicated asthma, children aged 2–14 years, by ethnic group, 2016/17 (unadjusted prevalence)
Children living in the most deprived areas had a much higher rate of medicated asthma (17.0%) than children in the least deprived areas (11.7%) (Figure 6).
Figure 6: Prevalence of medicated asthma, children aged 2–14 years, by NZDep2013 quintiles, 2016/17 (unadjusted prevalence)
In 2014–2017, the District Health Boards (DHBs) with the highest rates of medicated asthma were Whanganui DHB (24.4%), MidCentral DHB (21.8%) and Hutt Valley DHB (20.5%).
Figure 7: Prevalence of medicated asthma, children aged 2–14 years, by District Health Board, 2014–17 (unadjusted prevalence)
See the factsheet for more details (in the Downloads box).
Source: National Minimum Dataset, Ministry of Health
Definition: Acute and semi-acute hospitalisations with asthma (ICD-10AM J45–J46) or wheeze (R06.2) as the primary diagnosis, for children aged 0–14 years. Analyses excluded overseas visitors, deaths, and transfers within and between hospitals. Age-standardised rates per 100,000 people have been presented.
Source: New Zealand Health Survey, Ministry of Health
Definition: Children aged 2–14 years who have been diagnosed by a doctor as having asthma, and who currently take medication (inhalers, medicine, tablets, pills or other medication) for it.
For more information about these indicators, see the metadata sheets (in the Downloads box).
1. U.S. Department of Health and Human Services. 2007. Children and Secondhand Smoke Exposure. Excerpts from The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
2. Belanger K, Holford TR, Gent JF, Hill ME, Kezik JM, Leaderer BP. 2013. Household levels of nitrogen dioxide and pediatric asthma severity. Epidemiology 24(2): 320–330.
3. Pilotto LS, Nitschke M, Smith BJ, Ruffin RE, McElroy HJ, Martin J, Hiller JE. 2004. Randomized controlled trial of unflued gas heater replacement on respiratory health of asthmatic schoolchildren. Int J Epidemiol. 33(1): 208–214.
4. Jaakkola MS, Haverinen-Shaughnessy U, Douwes J, Nevalainen A. 2011. Indoor dampness and mould problems in homes and asthma onset in children. In M. Braubach, D.E. Jacobs & D. Ormandy (Eds.), Environmental burden of disease associated with inadequate housing: A method guide to the quantification of health effects of selected housing risks in the WHO European Region (pp. 5–31). Copenhagen: World Health Organization Regional Office for Europe.
5. Orellano P, Quaranta N, Reynoso J, Balbi B, Vasquez J. 2017. Effect of outdoor air pollution on asthma exacerbations in children and adults: Systematic review and multilevel meta-analysis. PLoS ONE 12(3): e0174050.
6. Prezant B, Douwes J. 2011. Calculating the burden of disease attributable to indoor dampness in New Zealand: Technical Report. Wellington: Centre for Public Health Research.
7. Lai CKW, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. 2009. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 64: 476–483.
8. OECD. 2015. CO1.6: Disease-based indicators: prevalence of diabetes and asthma among children. OECD Family Database. Available online: https://www.oecd.org/els/family/CO_1_6_Diabetes_Asthma_Children.pdf (accessed 30/10/2017).